• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol . Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated P

tetano

Editor, Senior Moderator
J Virol


. 2020 Dec 2;JVI.01787-20.
doi: 10.1128/JVI.01787-20. Online ahead of print.
Vaccines That Reduce Viral Shedding Do Not Prevent Transmission of H1N1 Pandemic 2009 Swine Influenza a Virus Infection to Unvaccinated Pigs


Helen E Everett[SUP] 1 [/SUP], Pauline M van Diemen[SUP] 2 [/SUP], Mario Aramouni[SUP] 3 [/SUP], Andrew Ramsay[SUP] 2 [/SUP], Vivien J Coward[SUP] 2 [/SUP], Vincent Pavot[SUP] 3 [/SUP], Laetitia Canini[SUP] 4 [/SUP], Barbara Holzer[SUP] 5 [/SUP], Sophie Morgan[SUP] 5 [/SUP], Dynamics sLoLa Consortium; Mark E J Woolhouse[SUP] 4 [/SUP], Elma Tchilian[SUP] 5 [/SUP], Sharon M Brookes[SUP] 2 [/SUP], Ian H Brown[SUP] 2 [/SUP], Bryan Charleston[SUP] 5 [/SUP], Sarah Gilbert[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Swine influenza A virus (swIAV) infection causes substantial economic loss and disease burden in humans and animals. The 2009 pandemic H1N1 (pH1N1) influenza A virus is now endemic in both populations. In this study we evaluated the efficacy of different vaccines in reducing nasal shedding in pigs following pH1N1 virus challenge. We also assessed transmission from immunized and challenged to naive, directly in-contact pigs. Pigs were immunised with either adjuvanted, whole inactivated virus (WIV) vaccines or viral vectored (ChAdOx1 and MVA) vaccines expressing either the homologous or heterologous influenza A virus hemagglutinin (HA) glycoprotein as well as an influenza viral pseudotype (S-FLU) vaccine expressing heterologous HA. Only two vaccines containing homologous HA, which also induced high hemagglutination inhibitory antibody titers, significantly reduced virus shedding in challenged animals. Nevertheless, virus transmission from challenged to naive, in-contact animals occurred in all groups, although was delayed in groups of vaccinated animals with reduced virus shedding.IMPORTANCE This study was designed to determine whether vaccination of pigs with conventional, WIV or viral-vectored vaccines reduces pH1N1 swine influenza virus shedding following challenge and can prevent transmission to naive in-contact animals. Even when viral shedding was significantly reduced following challenge, infection was transmissible to susceptible co-housed recipients. This knowledge is important to inform disease surveillance and control strategies, and to determine the vaccine coverage required in a population, thereby defining disease moderation or herd protection. WIV or viral-vectored vaccines homologous to the challenge strain significantly reduced virus shedding from directly infected pigs, but vaccination did not completely prevent transmission to co-housed naive pigs.
 
Back
Top Bottom